Stock ENTA ENANTA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Enanta Pharmaceuticals, Inc.

Equities

ENTA

US29251M1062

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-01 pm EDT 		5-day change 1st Jan Change
13.56 USD -1.31% Intraday chart for Enanta Pharmaceuticals, Inc. +4.95% +44.10%
Apr. 30 Enanta Pharmaceuticals, Inc. Appoints Matthew P. Kowalsky as Chief Legal Officer CI
Feb. 09 Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $17 From $21, Maintains Perform Rating MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. ENTA Stock
  4. News Enanta Pharmaceuticals, Inc.
  5. Official Publications